Evidence map›Paper›PMID 31885644›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2019

Nephroprotective Role of

Gadah Albasher, Rafa Almeer, Saud Alarifi, Saad Alkhtani, Manal Farhood, Fatimah O Al-Otibi, Noorah Alkubaisi, Humaira Rizwana

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Nephroprotective and Anti-Diabetic Potential ofMedicina (Kaunas, Lithuania) · 2024
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gadah AlbasherKing Saud University, Department of Zoology, College of Science, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-3755-7534
Rafa AlmeerKing Saud University, Department of Zoology, College of Science, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-1624-3109
Saud AlarifiKing Saud University, Department of Zoology, College of Science, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-3613-5228
Saad AlkhtaniKing Saud University, Department of Zoology, College of Science, Riyadh, Saudi Arabia.
Manal FarhoodKing Saud University, Department of Zoology, College of Science, Riyadh, Saudi Arabia.
Fatimah O Al-OtibiKing Saud University, Department of Botany and Microbiology, College of Science, Riyadh, Saudi Arabia.
Noorah AlkubaisiKing Saud University, Department of Botany and Microbiology, College of Science, Riyadh, Saudi Arabia.
Humaira RizwanaKing Saud University, Department of Botany and Microbiology, College of Science, Riyadh, Saudi Arabia.
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organophosphorus pesticides (OPs) are widely used for agricultural and housekeeping purposes. Exposure to OPs is associated with the progression of several health issues. Antioxidant agents may be powerful candidates to minimise adverse reactions caused by OPs. The aim of the present study was to evaluate the nephroprotective effects of red beetroot extract (RBR) against chlorpyrifos- (CPF-) induced renal impairments. CPF induced kidney dysfunction, as demonstrated by changes in serum creatinine and urea levels. Moreover, CPF exposure induced oxidative stress in the kidneys as determined by increased malondialdehyde and nitric oxide levels, decreased glutathione content, decreased catalase, superoxide dismutase, glutathione peroxidase, and glutathione reductase activities, and decreased nuclear factor (erythroid-derived 2)-like-2 factor expression. In addition, CPF induced inflammation in renal tissue as evidenced by increased release of tumor necrosis factor-alpha and interleukin-1

Identifiers

PMID31885644
PMCPMC6893258
OpenAlexW2989667891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.